Cite

HARVARD Citation

    Rogiers, A. et al. (2021). Clinical impact of COVID-19 on patients with cancer treated with immune checkpoint inhibition. Journal for immunotherapy of cancer. 9 (1), p. . [Online]. 
  
Back to record